Wound Care Dermatology Partnership: Complementary Care

Wound Care Dermatology Partnership: When Skin Needs Both Specialists

A wound care dermatology partnership recognizes that these are complementary specialties, not competing ones. Every wound care clinician encounters wounds that demand dermatologic evaluation — atypical presentations, non-healing wounds suspicious for malignancy, autoimmune-mediated tissue breakdown, and medication-related skin complications. Simultaneously, dermatologists encounter surgical wounds, chronic skin breakdown, and post-procedural complications that require wound management expertise beyond their typical scope.

A structured wound care dermatology partnership creates a bidirectional referral pathway that improves outcomes for both patient populations and generates sustainable referral volume for both practices. This is not about informal "I know a dermatologist" relationships. It is about defined clinical triggers, communication protocols, and co-management agreements that make the referral pathway reliable and repeatable.

Clinical Triggers for Dermatology Referral

Not every wound needs dermatology input. The value of a structured partnership is knowing exactly when to activate it. These are the clinical scenarios where wound care clinicians should refer to dermatology.

Atypical Wounds Requiring Biopsy

A wound that does not follow expected healing trajectories and lacks a clear etiology is a biopsy candidate. Specific triggers include:

Wounds that fail to show healing progress after 4-6 weeks of appropriate treatment
Wound margins that appear rolled, raised, or undermined without mechanical cause
Wounds with unusual tissue coloring (violaceous borders suggesting pyoderma gangrenosum, pearly borders suggesting basal cell carcinoma)
Non-healing ulcers in areas not typical for pressure, venous, or arterial etiology
Wounds in patients with history of skin cancer at or near the wound site

The tissue biopsy determines whether the wound is inflammatory, malignant, or infectious — and changes the treatment plan entirely. A wound that presents as a chronic non-healing ulcer but is actually squamous cell carcinoma requires surgical excision, not debridement. Missing this distinction delays definitive treatment and puts the patient at risk. For more on the biopsy referral decision, see Wound Care Tissue Biopsy Referral.

Skin Cancer and Wound Overlap

Skin cancer — particularly basal cell carcinoma and squamous cell carcinoma — can present as or within chronic wounds. Marjolin ulcers (squamous cell carcinoma arising in chronic wound beds) are the classic example, but primary skin cancers can also erode into wound-like lesions. Dermatology should evaluate any wound with features suggestive of malignancy: irregular borders, rapid tissue destruction inconsistent with the wound etiology, or recurrence after appropriate surgical closure.

Autoimmune and Inflammatory Conditions

Several autoimmune conditions produce wounds that require dermatologic management alongside wound care:

Pyoderma gangrenosum: Rapidly progressive, painful ulcers with violaceous undermined borders. Debridement can worsen PG — the pathergy response means surgical intervention on the wound can trigger expansion. Dermatology manages the systemic immunosuppressive therapy while wound care manages the local wound environment
Vasculitis: Cutaneous vasculitis produces palpable purpura, ulceration, and tissue necrosis. The underlying vascular inflammation requires systemic treatment directed by dermatology or rheumatology
Calciphylaxis: Calcific uremic arteriolopathy produces excruciatingly painful necrotic wounds in dialysis patients. Dermatology confirms the diagnosis (typically via punch biopsy) and coordinates systemic management

Medication-Related Skin Breakdown

Wound care clinicians encounter skin complications from medications — particularly anticoagulants (warfarin necrosis, heparin-induced skin necrosis), hydroxyurea (leg ulcers), and immunosuppressants. Dermatology evaluates whether the medication is causative and coordinates with the prescribing provider on alternatives.

Building the Bidirectional Referral Pathway

A wound care dermatology partnership works in both directions. Wound care refers patients to dermatology for the scenarios above. Dermatology refers patients to wound care for:

Post-Mohs surgery wound management, particularly on the lower extremities or in patients with comorbidities that impair healing
Post-excisional wounds that dehisce or develop complications
Chronic skin breakdown in dermatology patients with venous disease, diabetes, or peripheral arterial disease
Wound management for patients on immunosuppressive therapy with recurrent skin ulceration

Co-Management Protocol

Effective co-management requires a defined communication structure:

Referral documentation: Include wound photographs, measurement history, treatment history, and the specific clinical question ("rule out malignancy in non-healing right lateral malleolus wound, 8 weeks without progress")
Biopsy results communication: Dermatology shares pathology results and recommended treatment modifications within 48 hours of result availability
Parallel treatment plans: When dermatology initiates systemic therapy (e.g., prednisone for pyoderma gangrenosum), wound care adjusts local wound management accordingly and documents the coordination
Follow-up cadence: Define who follows the patient at what intervals. Avoid duplicative visits that create patient burden and payer scrutiny

For strategies on building and managing specialist referral relationships, see Wound Care Referral Strategy.

Reimbursement Considerations

Co-managed patients generate separate billable visits for each specialty. There is no "shared visit" or split billing concern when each provider is performing distinct services within their scope:

Wound care bills for wound assessment, debridement, dressing changes, and wound-specific E/M
Dermatology bills for the biopsy, pathology interpretation, and dermatologic management

Document the distinct services clearly. If both providers see the patient on the same day (e.g., in a shared clinic setting), ensure each note reflects independent clinical decision-making and distinct procedures.

Key Takeaways

Refer to dermatology when wounds fail to heal after 4-6 weeks without clear cause, when wound margins show features suggestive of malignancy, or when autoimmune conditions (pyoderma gangrenosum, vasculitis, calciphylaxis) are suspected
Never debride a suspected pyoderma gangrenosum wound without dermatology confirmation — the pathergy response can cause rapid wound expansion after surgical intervention
Build the partnership as a bidirectional referral pathway where dermatology sends post-surgical and chronic skin breakdown patients to wound care, creating sustainable volume for both practices
Co-management requires a defined communication protocol including referral documentation standards, biopsy result turnaround expectations, and coordinated treatment plan updates